Cargando…

Current therapies and new developments in NASH

Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufour, Jean-François, Anstee, Quentin M, Bugianesi, Elisabetta, Harrison, Stephen, Loomba, Rohit, Paradis, Valerie, Tilg, Herbert, Wong, Vincent Wai-Sun, Zelber-sagi, Shira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484366/
https://www.ncbi.nlm.nih.gov/pubmed/35710299
http://dx.doi.org/10.1136/gutjnl-2021-326874
_version_ 1784791867203780608
author Dufour, Jean-François
Anstee, Quentin M
Bugianesi, Elisabetta
Harrison, Stephen
Loomba, Rohit
Paradis, Valerie
Tilg, Herbert
Wong, Vincent Wai-Sun
Zelber-sagi, Shira
author_facet Dufour, Jean-François
Anstee, Quentin M
Bugianesi, Elisabetta
Harrison, Stephen
Loomba, Rohit
Paradis, Valerie
Tilg, Herbert
Wong, Vincent Wai-Sun
Zelber-sagi, Shira
author_sort Dufour, Jean-François
collection PubMed
description Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been tested. The importance of lifestyle has been recognised and several drugs are being tested in clinical trials. This review addresses the challenges that healthcare professionals face in the management of NASH patients.
format Online
Article
Text
id pubmed-9484366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94843662022-09-20 Current therapies and new developments in NASH Dufour, Jean-François Anstee, Quentin M Bugianesi, Elisabetta Harrison, Stephen Loomba, Rohit Paradis, Valerie Tilg, Herbert Wong, Vincent Wai-Sun Zelber-sagi, Shira Gut Recent Advances in Clinical Practice Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been tested. The importance of lifestyle has been recognised and several drugs are being tested in clinical trials. This review addresses the challenges that healthcare professionals face in the management of NASH patients. BMJ Publishing Group 2022-10 2022-06-16 /pmc/articles/PMC9484366/ /pubmed/35710299 http://dx.doi.org/10.1136/gutjnl-2021-326874 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Recent Advances in Clinical Practice
Dufour, Jean-François
Anstee, Quentin M
Bugianesi, Elisabetta
Harrison, Stephen
Loomba, Rohit
Paradis, Valerie
Tilg, Herbert
Wong, Vincent Wai-Sun
Zelber-sagi, Shira
Current therapies and new developments in NASH
title Current therapies and new developments in NASH
title_full Current therapies and new developments in NASH
title_fullStr Current therapies and new developments in NASH
title_full_unstemmed Current therapies and new developments in NASH
title_short Current therapies and new developments in NASH
title_sort current therapies and new developments in nash
topic Recent Advances in Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484366/
https://www.ncbi.nlm.nih.gov/pubmed/35710299
http://dx.doi.org/10.1136/gutjnl-2021-326874
work_keys_str_mv AT dufourjeanfrancois currenttherapiesandnewdevelopmentsinnash
AT ansteequentinm currenttherapiesandnewdevelopmentsinnash
AT bugianesielisabetta currenttherapiesandnewdevelopmentsinnash
AT harrisonstephen currenttherapiesandnewdevelopmentsinnash
AT loombarohit currenttherapiesandnewdevelopmentsinnash
AT paradisvalerie currenttherapiesandnewdevelopmentsinnash
AT tilgherbert currenttherapiesandnewdevelopmentsinnash
AT wongvincentwaisun currenttherapiesandnewdevelopmentsinnash
AT zelbersagishira currenttherapiesandnewdevelopmentsinnash